India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 975.85 billion. The enterprise value is 975.71 billion.
| Market Cap | 975.85B |
| Enterprise Value | 975.71B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 25, 2025 |
Share Statistics
NSE:ZYDUSLIFE has 1.01 billion shares outstanding. The number of shares has decreased by -0.56% in one year.
| Current Share Class | 1.01B |
| Shares Outstanding | 1.01B |
| Shares Change (YoY) | -0.56% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 75.09% |
| Owned by Institutions (%) | 13.82% |
| Float | 248.90M |
Valuation Ratios
The trailing PE ratio is 21.56 and the forward PE ratio is 21.56. NSE:ZYDUSLIFE's PEG ratio is 3.33.
| PE Ratio | 21.56 |
| Forward PE | 21.56 |
| PS Ratio | 4.20 |
| PB Ratio | 3.70 |
| P/TBV Ratio | 6.30 |
| P/FCF Ratio | 19.27 |
| P/OCF Ratio | 14.40 |
| PEG Ratio | 3.33 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.13, with an EV/FCF ratio of 19.27.
| EV / Earnings | 21.56 |
| EV / Sales | 4.20 |
| EV / EBITDA | 14.13 |
| EV / EBIT | 16.21 |
| EV / FCF | 19.27 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.89 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | 0.64 |
| Interest Coverage | 63.75 |
Financial Efficiency
Return on equity (ROE) is 19.28% and return on invested capital (ROIC) is 14.19%.
| Return on Equity (ROE) | 19.28% |
| Return on Assets (ROA) | 11.21% |
| Return on Invested Capital (ROIC) | 14.19% |
| Return on Capital Employed (ROCE) | 21.17% |
| Revenue Per Employee | 8.33M |
| Profits Per Employee | 1.62M |
| Employee Count | 27,917 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, NSE:ZYDUSLIFE has paid 14.12 billion in taxes.
| Income Tax | 14.12B |
| Effective Tax Rate | 23.20% |
Stock Price Statistics
The stock price has decreased by -20.47% in the last 52 weeks. The beta is 0.49, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | -20.47% |
| 50-Day Moving Average | 966.05 |
| 200-Day Moving Average | 946.34 |
| Relative Strength Index (RSI) | 48.11 |
| Average Volume (20 Days) | 869,816 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 232.42 billion and earned 45.26 billion in profits. Earnings per share was 44.97.
| Revenue | 232.42B |
| Gross Profit | 167.03B |
| Operating Income | 59.60B |
| Pretax Income | 60.85B |
| Net Income | 45.26B |
| EBITDA | 68.30B |
| EBIT | 59.60B |
| Earnings Per Share (EPS) | 44.97 |
Balance Sheet
The company has 56.37 billion in cash and 32.18 billion in debt, giving a net cash position of 24.19 billion or 24.04 per share.
| Cash & Cash Equivalents | 56.37B |
| Total Debt | 32.18B |
| Net Cash | 24.19B |
| Net Cash Per Share | 24.04 |
| Equity (Book Value) | 263.58B |
| Book Value Per Share | 238.05 |
| Working Capital | 80.05B |
Cash Flow
In the last 12 months, operating cash flow was 67.77 billion and capital expenditures -17.13 billion, giving a free cash flow of 50.64 billion.
| Operating Cash Flow | 67.77B |
| Capital Expenditures | -17.13B |
| Free Cash Flow | 50.64B |
| FCF Per Share | 50.33 |
Margins
Gross margin is 71.87%, with operating and profit margins of 25.64% and 19.47%.
| Gross Margin | 71.87% |
| Operating Margin | 25.64% |
| Pretax Margin | 26.18% |
| Profit Margin | 19.47% |
| EBITDA Margin | 29.39% |
| EBIT Margin | 25.64% |
| FCF Margin | 21.79% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 1.11%.
| Dividend Per Share | 11.00 |
| Dividend Yield | 1.11% |
| Dividend Growth (YoY) | 266.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.68% |
| Buyback Yield | 0.56% |
| Shareholder Yield | 1.67% |
| Earnings Yield | 4.64% |
| FCF Yield | 5.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
NSE:ZYDUSLIFE has an Altman Z-Score of 8.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 8.06 |
| Piotroski F-Score | 5 |